129 related articles for article (PubMed ID: 9951775)
1. Enhanced osteoblast development after continuous infusion of hPTH(1-84) in the rat.
Watson PH; Fraher LJ; Kisiel M; DeSousa D; Hendy G; Hodsman AB
Bone; 1999 Feb; 24(2):89-94. PubMed ID: 9951775
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats.
Watson P; Lazowski D; Han V; Fraher L; Steer B; Hodsman A
Bone; 1995 Mar; 16(3):357-65. PubMed ID: 7786639
[TBL] [Abstract][Full Text] [Related]
3. Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation.
Ma YL; Cain RL; Halladay DL; Yang X; Zeng Q; Miles RR; Chandrasekhar S; Martin TJ; Onyia JE
Endocrinology; 2001 Sep; 142(9):4047-54. PubMed ID: 11517184
[TBL] [Abstract][Full Text] [Related]
4. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
[TBL] [Abstract][Full Text] [Related]
7. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I.
Kostenuik PJ; Harris J; Halloran BP; Turner RT; Morey-Holton ER; Bikle DD
J Bone Miner Res; 1999 Jan; 14(1):21-31. PubMed ID: 9893062
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor I suppresses parathyroid hormone (PTH)/PTH-related protein receptor expression via a mitogen-activated protein kinase pathway in UMR-106 osteoblast-like cells.
Kawane T; Horiuchi N
Endocrinology; 1999 Feb; 140(2):871-9. PubMed ID: 9927318
[TBL] [Abstract][Full Text] [Related]
9. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
Koh AJ; Beecher CA; Rosol TJ; McCauley LK
Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
[TBL] [Abstract][Full Text] [Related]
10. Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone.
Locklin RM; Khosla S; Turner RT; Riggs BL
J Cell Biochem; 2003 May; 89(1):180-90. PubMed ID: 12682918
[TBL] [Abstract][Full Text] [Related]
11. The expression of insulin-like growth factor-I mRNA and polypeptide in rat osteoblasts with exposure to parathyroid hormone.
Zhang K; Chen J; Wang M; Wang C; Li G; Zheng Z; Zhao R
Chin Med J (Engl); 2003 Dec; 116(12):1916-22. PubMed ID: 14687484
[TBL] [Abstract][Full Text] [Related]
12. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats.
Schmidt IU; Dobnig H; Turner RT
Endocrinology; 1995 Nov; 136(11):5127-34. PubMed ID: 7588250
[TBL] [Abstract][Full Text] [Related]
13. In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment.
Stanislaus D; Yang X; Liang JD; Wolfe J; Cain RL; Onyia JE; Falla N; Marder P; Bidwell JP; Queener SW; Hock JM
Bone; 2000 Aug; 27(2):209-18. PubMed ID: 10913913
[TBL] [Abstract][Full Text] [Related]
14. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.
Dobnig H; Turner RT
Endocrinology; 1997 Nov; 138(11):4607-12. PubMed ID: 9348185
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).
Nakajima A; Shimoji N; Shiomi K; Shimizu S; Moriya H; Einhorn TA; Yamazaki M
J Bone Miner Res; 2002 Nov; 17(11):2038-47. PubMed ID: 12412812
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone potentiates the effect of insulin-like growth factor-I on bone formation.
Spencer EM; Si EC; Liu CC; Howard GA
Acta Endocrinol (Copenh); 1989 Sep; 121(3):435-42. PubMed ID: 2800920
[TBL] [Abstract][Full Text] [Related]
17. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing.
Nakazawa T; Nakajima A; Shiomi K; Moriya H; Einhorn TA; Yamazaki M
Bone; 2005 Nov; 37(5):711-9. PubMed ID: 16143574
[TBL] [Abstract][Full Text] [Related]
18. Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts.
Hilal G; Massicotte F; Martel-Pelletier J; Fernandes JC; Pelletier JP; Lajeunesse D
J Bone Miner Res; 2001 Apr; 16(4):713-21. PubMed ID: 11315999
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts.
Schmid C; Schläpfer I; Peter M; Böni-Schnetzler M; Schwander J; Zapf J; Froesch ER
Am J Physiol; 1994 Aug; 267(2 Pt 1):E226-33. PubMed ID: 7521133
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3',5'-monophosphate-dependent mechanism.
Tørring O; Firek AF; Heath H; Conover CA
Endocrinology; 1991 Feb; 128(2):1006-14. PubMed ID: 1703477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
